28 assets in Diffuse Intrinsic Pontine Glioma

Therapeutic assets addressing Diffuse Intrinsic Pontine Glioma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Irinotecan Diffuse Intrinsic Pontine Glioma	Actuate Therapeutics Inc.	P2	BB (65)
Cyclophosphamide Diffuse Intrinsic Pontine Glioma	Shenzhen Geno-Immune Medical Institute	P2	B (58)
Etoposide Diffuse Intrinsic Pontine Glioma	Theodore S. Johnson	P2	B (58)
Everolimus Diffuse Intrinsic Pontine Glioma	Nationwide Children's Hospital	P2	B (58)
Indoximod Diffuse Intrinsic Pontine Glioma	Theodore S. Johnson	P2	B (58)
Nogitecan Diffuse Intrinsic Pontine Glioma	Actuate Therapeutics Inc.	P2	B (58)
Ribociclib Diffuse Intrinsic Pontine Glioma	Nationwide Children's Hospital	P2	B (58)
Lomustine Diffuse Intrinsic Pontine Glioma	Theodore S. Johnson	P2	CCC (53)
Olutasidenib Diffuse Intrinsic Pontine Glioma	Rigel Pharmaceuticals	P2	CCC (53)
Palbociclib Diffuse Intrinsic Pontine Glioma	Pfizer	P2	CCC (53)
Amxt1501 Diffuse Intrinsic Pontine Glioma	Aminex Therapeutics, Inc.	P1/2	CCC (48)
Cetuximab Diffuse Intrinsic Pontine Glioma	University of Miami	P1/2	CCC (48)
Cobolimab Diffuse Intrinsic Pontine Glioma	GlaxoSmithKline	P1/2	CCC (48)
Dostarlimab Diffuse Intrinsic Pontine Glioma	GlaxoSmithKline	P1/2	CCC (48)
Eflornithine Diffuse Intrinsic Pontine Glioma	Aminex Therapeutics, Inc.	P1/2	CCC (48)
Olaparib Diffuse Intrinsic Pontine Glioma	Fundación de investigación HM	P1/2	CCC (48)
Oxodotreotide Diffuse Intrinsic Pontine Glioma	Fundación de investigación HM	P1/2	CCC (48)
Cbl-0137 Free Base Diffuse Intrinsic Pontine Glioma	Children's Oncology Group	P1/2	CC (44)
Sargramostim Diffuse Intrinsic Pontine Glioma	Children's Oncology Group	P1	CC (44)
Anti-Egfr Antibody-Drug Conjugate Mrg003 Diffuse Intrinsic Pontine Glioma	Sun Yat-sen University	P1	CC (43)
Iopofosine (¹³¹I) Diffuse Intrinsic Pontine Glioma	Cellectar Biosciences, Inc.	P1	CC (43)
Pembrolizumab Diffuse Intrinsic Pontine Glioma	National Cancer Institute (NCI)	P1	CC (43)
Sotigalimab Diffuse Intrinsic Pontine Glioma	Pediatric Brain Tumor Consortium	P1	CC (42)
Ex-Vivo Expanded Autologous Il-8 Receptor Modified Cd70 Car T Cells Diffuse Intrinsic Pontine Glioma	University of Florida	P1	CC (41)
Survaxm Diffuse Intrinsic Pontine Glioma	Children's Oncology Group	P1	CC (41)
Fimepinostat Diffuse Intrinsic Pontine Glioma	Sabine Mueller, MD, PhD	Early P1	C (38)
Lorlatinib Diffuse Intrinsic Pontine Glioma	Nationwide Children's Hospital	Early P1	C (38)
azd1390 Diffuse Intrinsic Pontine Glioma	Children's Oncology Group	P1	NR ()